Department of Mathematics and Physics 'E. De Giorgi', Università del Salento, 73100 Lecce, Italy.
CNR NANOTEC-Institute of Nanotechnology, 73100 Lecce, Italy.
Biofabrication. 2023 Feb 14;15(2). doi: 10.1088/1758-5090/acb571.
The human Blood Brain Barrier (hBBB) is a complex cellular architecture separating the blood from the brain parenchyma. Its integrity and perfect functionality are essential for preventing neurotoxic plasma components and pathogens enter the brain. Although vital for preserving the correct brain activity, the low permeability of hBBB represents a huge impediment to treat mental and neurological disorders or to address brain tumors. Indeed, the vast majority of potential drug treatments are unable to reach the brain crossing the hBBB. On the other hand, hBBB integrity can be damaged or its permeability increase as a result of infections or in presence of neurodegenerative diseases. Currentsystems andanimal models used to study the molecular/drug transport mechanism through the hBBB have several intrinsic limitations that are difficult to overcome. In this scenario, Organ-on-Chip (OoC) models based on microfluidic technologies are considered promising innovative platforms that combine the handiness of anmodel with the complexity of a living organ, while reducing time and costs. In this review, we focus on recent advances in OoCs for developing hBBB models, with the aim of providing the reader with a critical overview of the main guidelines to design and manufacture a hBBB-on-chip, whose compartments need to mimic the 'blood side' and 'brain side' of the barrier, to choose the cells types that are both representative and convenient, and to adequately evaluate the barrier integrity, stability, and functionality.
人类血脑屏障(hBBB)是一种复杂的细胞结构,将血液与脑实质分隔开来。其完整性和完美的功能对于防止神经毒性血浆成分和病原体进入大脑至关重要。尽管 hBBB 对于维持大脑的正常活动至关重要,但它的低通透性极大地阻碍了对精神和神经紊乱的治疗,或对脑肿瘤的治疗。事实上,绝大多数潜在的药物治疗都无法穿透 hBBB 进入大脑。另一方面,hBBB 的完整性可能会因感染或神经退行性疾病而受损或通透性增加。目前用于研究分子/药物通过 hBBB 的运输机制的系统和动物模型存在一些难以克服的内在局限性。在这种情况下,基于微流控技术的器官芯片(OoC)模型被认为是很有前途的创新平台,它结合了模型的便利性和活体器官的复杂性,同时减少了时间和成本。在这篇综述中,我们重点介绍了用于开发 hBBB 模型的 OoC 的最新进展,旨在为读者提供关于设计和制造 hBBB-on-chip 的主要指导方针的批判性概述,这些芯片的腔室需要模拟屏障的“血液侧”和“大脑侧”,选择既具有代表性又方便的细胞类型,并充分评估屏障的完整性、稳定性和功能。